Showing results (1-10 of 34) with videos related to
Sort By:
Pageof 4
Current Pharmaceutical Design|August 25, 2011
Susceptibility genes in hypertensionC Armani, N Botto, M G AndreassiJournal of Internal Medicine|September 16, 2004
Oxidative stress and its association with coronary artery disease and different atherogenic risk factorsC Vassalle, L Petrozzi, N Botto, et al.Environmental and Molecular Mutagenesis|June 22, 2000
Genetic instability and atherosclerosis: can somatic mutations account for the development of cardiovascular diseases?M G Andreassi, N Botto, M G Colombo, et al.The British Journal of Radiology|May 30, 2008
Cumulative patient effective dose in cardiologyG Bedetti, N Botto, M G Andreassi, et al.Climacteric : the Journal of the International Menopause Society|November 16, 2010
Prothrombotic mutations, family history and the risk of thrombosis in postmenopausal women: implications for hormone replacement therapyN Botto, S Maffei, S Manfredi, et al.Heart (British Cardiac Society)|May 16, 2002
Evidence for association of a common variant of the endothelial nitric oxide synthase gene (Glu298-->Asp polymorphism) to the presence, extent, and severity of coronary artery diseaseM G Colombo, M G Andreassi, U Paradossi, et al.Mutagenesis|October 30, 2001
Chronic long-term nitrate therapy: possible cytogenetic effect in humans?M G Andreassi, E Picano, S Del Ry, et al.Mutation Research|August 23, 2001
Evidence for DNA damage in patients with coronary artery diseaseN Botto, A Rizza, M G Colombo, et al.Current Pharmaceutical Design|April 10, 2009
Molecular and biochemical changes of the cardiovascular system due to smoking exposureC Armani, L Landini, A LeoneMinerva Endocrinologica|March 25, 2000
[Physiological significance and clinical utility of analytical methods for cardiac natriuretic peptides]S Del Ry, M G Andreassi, D Giannessi, et al.Pageof 4